BioCentury | Feb 2, 2018
Clinical News
Takeda, Zinfandel's AD test fails to deliver
...AD within five years. The algorithm has three components: apolipoprotein E (APOE) genotype, translocase of outer mitochondrial membrane 40 homolog (TOMM40; TOM40...
...TOMM40; TOM40) genotype and age. Takeda has exclusive, worldwide rights to develop and commercialize Zinfandel’s TOMM40...
...TOMM40; TOM40) genotype and age. Takeda has exclusive, worldwide rights to develop and commercialize Zinfandel’s TOMM40...